Adagio Medical (ADGM) Competitors $1.98 +0.04 (+2.06%) Closing price 04:00 PM EasternExtended Trading$1.96 -0.01 (-0.76%) As of 06:33 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFDA EventsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock ADGM vs. SVII, PELI, SIEB, GLDI, LFT, KVAC, CNDA, BIOX, SPKL, and BKHAShould you be buying Adagio Medical stock or one of its competitors? The main competitors of Adagio Medical include Spring Valley Acquisition Corp. II (SVII), Pelican Acquisition (PELI), Siebert Financial (SIEB), ETRACS Gold Shares Covered Call ETN (GLDI), Lument Finance Trust (LFT), Keen Vision Acquisition (KVAC), Concord Acquisition Corp II (CNDA), Bioceres Crop Solutions (BIOX), Spark I Acquisition (SPKL), and Black Hawk Acquisition (BKHA). These companies are all part of the "trading" industry. Adagio Medical vs. Its Competitors Spring Valley Acquisition Corp. II Pelican Acquisition Siebert Financial ETRACS Gold Shares Covered Call ETN Lument Finance Trust Keen Vision Acquisition Concord Acquisition Corp II Bioceres Crop Solutions Spark I Acquisition Black Hawk Acquisition Spring Valley Acquisition Corp. II (NASDAQ:SVII) and Adagio Medical (NASDAQ:ADGM) are both small-cap trading companies, but which is the better business? We will compare the two companies based on the strength of their media sentiment, valuation, institutional ownership, earnings, profitability, risk, analyst recommendations and dividends. Which has more volatility and risk, SVII or ADGM? Spring Valley Acquisition Corp. II has a beta of -0.04, meaning that its share price is 104% less volatile than the S&P 500. Comparatively, Adagio Medical has a beta of 0.13, meaning that its share price is 87% less volatile than the S&P 500. Does the media favor SVII or ADGM? In the previous week, Adagio Medical had 1 more articles in the media than Spring Valley Acquisition Corp. II. MarketBeat recorded 2 mentions for Adagio Medical and 1 mentions for Spring Valley Acquisition Corp. II. Spring Valley Acquisition Corp. II's average media sentiment score of 0.97 beat Adagio Medical's score of 0.64 indicating that Spring Valley Acquisition Corp. II is being referred to more favorably in the media. Company Overall Sentiment Spring Valley Acquisition Corp. II Positive Adagio Medical Positive Is SVII or ADGM more profitable? Spring Valley Acquisition Corp. II has a net margin of 0.00% compared to Adagio Medical's net margin of -12,465.28%. Spring Valley Acquisition Corp. II's return on equity of 0.00% beat Adagio Medical's return on equity.Company Net Margins Return on Equity Return on Assets Spring Valley Acquisition Corp. IIN/A N/A N/A Adagio Medical -12,465.28%-248.26%-125.31% Do insiders & institutionals believe in SVII or ADGM? 89.8% of Spring Valley Acquisition Corp. II shares are owned by institutional investors. Comparatively, 48.1% of Adagio Medical shares are owned by institutional investors. 0.5% of Spring Valley Acquisition Corp. II shares are owned by insiders. Comparatively, 53.5% of Adagio Medical shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. Which has better earnings and valuation, SVII or ADGM? Spring Valley Acquisition Corp. II has higher earnings, but lower revenue than Adagio Medical. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSpring Valley Acquisition Corp. IIN/AN/AN/AN/AN/AAdagio Medical$266K114.50-$75.04MN/AN/A SummarySpring Valley Acquisition Corp. II beats Adagio Medical on 5 of the 9 factors compared between the two stocks. Get Adagio Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for ADGM and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ADGM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ADGM vs. The Competition Export to ExcelMetricAdagio MedicalMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$30.46M$6.86B$6.04B$10.50BDividend YieldN/A1.25%5.78%4.67%P/E RatioN/A26.5477.0626.31Price / Sales114.50198.52553.93176.56Price / CashN/A21.3538.6861.65Price / Book1.515.1212.766.42Net Income-$75.04M$178.07M$3.30B$276.84M7 Day Performance-7.48%0.98%1.92%-0.02%1 Month Performance22.98%6.67%5.51%6.96%1 Year Performance-29.29%28.28%70.66%29.86% Adagio Medical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ADGMAdagio Medical0.6292 of 5 stars$1.98+2.1%N/A-24.8%$30.46M$266K0.0087News CoverageGap UpSVIISpring Valley Acquisition Corp. IIN/A$12.35+0.2%N/A+11.4%$122.02MN/A0.00N/APositive NewsShort Interest ↓High Trading VolumePELIPelican AcquisitionN/A$10.04-0.1%N/AN/A$120.48MN/A0.001Short Interest ↑SIEBSiebert Financial1.991 of 5 stars$2.85-4.4%N/A+15.4%$118.08M$83.90M11.88120News CoverageGLDIETRACS Gold Shares Covered Call ETNN/A$167.57+0.3%N/A+8.4%$117.30MN/A214.901,247Positive NewsDividend IncreaseHigh Trading VolumeLFTLument Finance Trust2.1807 of 5 stars$2.10-1.2%N/A-20.0%$109.65M$122.13M11.03600KVACKeen Vision AcquisitionN/A$11.60+0.0%N/A+8.5%$107.14MN/A0.00N/APositive NewsGap UpCNDAConcord Acquisition Corp IIN/A$11.42flatN/AN/A$105.10MN/A0.002BIOXBioceres Crop Solutions3.4593 of 5 stars$1.67-1.2%$4.17+149.5%-82.1%$104.73M$333.30M-2.06500Positive NewsHigh Trading VolumeSPKLSpark I AcquisitionN/A$11.78+1.6%N/A+10.9%$102.02MN/A0.00N/APositive NewsBKHABlack Hawk AcquisitionN/A$11.11+0.1%N/A+9.0%$99.21MN/A0.00N/A Related Companies and Tools Related Companies Spring Valley Acquisition Corp. II Alternatives Pelican Acquisition Alternatives Siebert Financial Alternatives ETRACS Gold Shares Covered Call ETN Alternatives Lument Finance Trust Alternatives Keen Vision Acquisition Alternatives Concord Acquisition Corp II Alternatives Bioceres Crop Solutions Alternatives Spark I Acquisition Alternatives Black Hawk Acquisition Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ADGM) was last updated on 10/1/2025 by MarketBeat.com Staff From Our PartnersMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | Sponsored6-Figure Target for BTC by 2025Crypto ETF records broken – here's what’s next The biggest names in finance have built the infrastructure f...Crypto 101 Media | SponsoredBuilding The Infrastructure for the Coming Financial ResetWhile China pushes nearly $1 trillion through its new digital currency, one emerging company is quietly buildi...Intellistake | SponsoredThe Coin That Could Define Trump’s Crypto PresidencyWhen Trump returned to office, one of his first moves was to tap PayPal’s former COO, David Sacks, as a top ad...Weiss Ratings | SponsoredTilson: “I’m watching HOOD”A strange chasm is coming to Wall Street... It's already creating millionaires and billionaires at the fast...Stansberry Research | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredTrump is Fast-Tracking These Three CompaniesThe Trump administration is planning to invest DIRECTLY in a small sector of the stock market… And they just r...InvestorPlace | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Adagio Medical Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Adagio Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.